Bank of Nova Scotia Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Bank of Nova Scotia Trust's NVO Position: Q4 2024 in Review
Bank of Nova Scotia Trust sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,075 shares — an estimated $247K sold.
Bank of Nova Scotia Trust first reported a position in NVO in Q3 2017 and held it in 24 quarters. The position peaked at $622K in Q2 2021. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.
- Bank of Nova Scotia Trust reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
- Bank of Nova Scotia Trust sold 2,075 Novo Nordisk shares in Q4 2024, an estimated $247K.
- Bank of Nova Scotia Trust first reported a position in Novo Nordisk in Q3 2017 and held it in 24 quarters.
- Bank of Nova Scotia Trust's Novo Nordisk position peaked at $622K in Q2 2021.
- 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.
Based on Bank of Nova Scotia Trust's 13F filing for Q4 2024, filed 13 Feb 2025.